glp 1 approved for sleep apnea Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Syndrome Management: A Narrative Review Tirzepatide (Zepbound) – A New
Description
Recently, an oral GLP-1 receptor agonist has demonstrated promising results in phase 3 clinical trials
However, there is concern about an increased risk of hypoglycemia and ketotic hyperglycemia
This includes, for example, any gastrointestinal symptoms or disorders, sarcopenia, osteopenia, or osteoporosis
Sakaue S: OR = 0.78, 95% CI [0.760.80]
